The company is leaning on its subcutaneous technology to deliver long-acting options that could prevent patients from cycling through drugs.

We recently compiled a list of the 12 Best Low Price Pharma Stocks To Invest In Right Now. In this article, we are going to ...

Teva’s new chief executive Richard Francis highlighted the recent FDA approval of long-active schizophrenia therapy Uzedy (risperidone) as a key part of the company’s new “pivot to growth ...

FDA recently announced new safety requirements for DPD screening in cancer patients. Kristine Ashcraft, founder and CEO of ...

At a UN General Assembly meeting in 2018, Dr. David G. Poplack, Global HOPE founding director (now retired) discovered that Teva provides a significant portion of the medicines that treat ...

In this Pharmaceutical Executive video interview, Jen Butler, Chief Commercial Officer for Pleio, the role pharma should be playing in helping to ensure patients have access to health insights they ...